David Lowrance
2018
Compensation breakdown
Non-Equity Incentive Plan | $116,891 |
---|---|
Option Awards | $1,671,362 |
Salary | $365,000 |
Other | $22,000 |
Total | $2,175,253 |
Lowrance received $1.7M in option awards, accounting for 77% of the total pay in 2018.
Lowrance also received $116.9K in non-equity incentive plan, $365K in salary and $22K in other compensation.
Rankings
In 2018, David Lowrance's compensation ranked 5,292nd out of 14,244 executives tracked by ExecPay. In other words, Lowrance earned more than 62.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,292 | 63rd |
Manufacturing | 1,999 | 65th |
Chemicals And Allied Products | 731 | 66th |
Drugs | 611 | 66th |
Pharmaceutical Preparations | 471 | 66th |
Pay ratio
David Lowrance's Pay | $2,175,253 |
---|---|
Median Employee's Pay | $282,179 |
Pay Ratio | to 1 |
In 2018, the annual total compensation of David Lowrance was $2,175,253.
The annual total compensation of the median employee at Mast Therapeutics was $282,179.
The ratio of David Lowrance's pay to the pay of median employee was therefore to one.
Lowrance's colleagues
We found three more compensation records of executives who worked with David Lowrance at Mast Therapeutics in 2018.